A share price of Charles River Laboratories International Inc [CRL] is currently trading at $150.21, up 1.22%. An important factor to consider is whether the stock is rising or falling in short-term value. The CRL shares have gain 3.56% over the last week, with a monthly amount glided 9.86%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Charles River Laboratories International Inc [NYSE: CRL] stock has seen the most recent analyst activity on May 23, 2025, when Redburn Atlantic upgraded its rating to a Buy but kept the price target unchanged to $182 for it. Previously, TD Cowen upgraded its rating to Buy on May 14, 2025, and kept the price target unchanged to $179. On May 08, 2025, upgrade upgraded it’s rating to Outperform but maintained its price target of $170 on the stock. Goldman downgraded its rating to a Neutral and decreased its price target to $170 on March 21, 2025. Citigroup upgraded its rating to a Neutral and raised its price target to $175 on March 04, 2025. Redburn Atlantic upgraded its rating to Neutral for this stock on March 03, 2025, but kept the price target unchanged to $188. In a note dated January 22, 2025, William Blair downgraded an Mkt Perform rating on this stock.
Charles River Laboratories International Inc experienced fluctuations in its stock price throughout the past year between $91.86 and $254.15. Currently, Wall Street analysts expect the stock to reach $303.6 within the next 12 months. Charles River Laboratories International Inc [NYSE: CRL] shares were valued at $150.21 at the most recent close of the market. An investor can expect a potential return of 102.12% based on the average CRL price forecast.
Analyzing the CRL fundamentals
Trailing Twelve Months sales for Charles River Laboratories International Inc [NYSE:CRL] were 4.02B which represents -2.71% decline. Gross Profit Margin for this corporation currently stands at 0.32% with Operating Profit Margin at 0.05%, Pretax Profit Margin comes in at 0.01%, and Net Profit Margin reading is -0.01%. To continue investigating profitability, this company’s Return on Assets is posted at -0.0, Equity is -0.01 and Total Capital is 0.03. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.93.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 146.64 points at the first support level, and at 143.06 for the second support level. However, for the 1st resistance point, the stock is sitting at 153.15, and for the 2nd resistance point, it is at 156.08.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Charles River Laboratories International Inc [NYSE:CRL] is 1.43. On the other hand, the Quick Ratio is 1.16, and the Cash Ratio is 0.22. Considering the valuation of this stock, the price to sales ratio is 1.83, the price to book ratio is 2.31.
Transactions by insiders
Recent insider trading involved WALLMAN RICHARD F, Former Director, that happened on Jun 23 ’25 when 4000.0 shares were purchased. Director, MASSARO GEORGE completed a deal on May 15 ’25 to sell 140.0 shares. Meanwhile, Director MASSARO GEORGE sold 140.0 shares on May 14 ’25.
